Dose-adjusted EPOCH regimen as first-line treatment for non-Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis: a single-arm, open-label, phase II trial. (Record no. 29674985)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01507 a2200433 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250518040303.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 202104s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1592-8721 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.3324/haematol.2019.220301 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Liang, Jin-Hua |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20210427 |
245 00 - TITLE STATEMENT | |
Title | Dose-adjusted EPOCH regimen as first-line treatment for non-Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis: a single-arm, open-label, phase II trial. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Haematologica |
Date of publication, distribution, etc. | 01 2020 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | e29-e32 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial, Phase II; Letter; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cyclophosphamide |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Doxorubicin |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Etoposide |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Lymphohistiocytosis, Hemophagocytic |
General subdivision | diagnosis |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Lymphoma, Non-Hodgkin |
General subdivision | complications |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Prednisone |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Vincristine |
General subdivision | adverse effects |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Wang, Li |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Zhu, Hua-Yuan |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Qian, Jun |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Liao, Hui |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Wu, Jia-Zhu |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Xia, Yi |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Wu, Wei |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Cao, Lei |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Fan, Lei |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Li, Jian-Yong |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Xu, Wei |
773 0# - HOST ITEM ENTRY | |
Title | Haematologica |
Related parts | vol. 105 |
-- | no. 1 |
-- | p. e29-e32 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.3324/haematol.2019.220301">https://doi.org/10.3324/haematol.2019.220301</a> |
Public note | Available from publisher's website |
No items available.